Search

everythinglearnresearchcommunity

for

Search:↓

Scalp biopsies from dermatomyositis patients show chronic hair loss without scarring, with mucin and blood vessel changes being very common.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

Anti-MND antibodies are present in various diseases, not just PBC, and their levels don't correlate with disease activity or skin symptoms.

Skin disease activity scores can help decide when skin symptoms no longer affect the quality of life in patients with mild dermatomyositis.

A woman with dermatomyositis improved after treatment for neck panniculitis, suggesting similar treatment for related conditions.

Methotrexate is effective and well-tolerated in children for certain skin conditions but requires careful monitoring.

Non-white organ transplant patients have worse skin cancer outcomes due to later diagnosis and treatment.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Most patients with cutaneous dermatomyositis either improved or remained stable over 3.5 years.

Early referral to a pediatric rheumatologist and thorough evaluation are crucial for treating complex overlap syndromes effectively.

Juvenile dermatomyositis can worsen quickly and needs strong treatment.

Muse cells keep their special features and can become different cell types even after being frozen and thawed three times.

Polyunsaturated fatty acids, like arachidonic acid and eicosapentaenoic acid, can promote hair growth and may help treat hair loss.

Centrosomes are essential for healthy skin and hair growth, and their role is different from that of cilia.

The conclusion is that using light-sheet fluorescence microscopy with a special solution can effectively create detailed 3D images of human skin for dermatological research.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Tailored treatment plans are crucial for managing canine dermatomyositis-like disease.

Dermoscopy and trichoscopy are useful for diagnosing skin signs in Dermatomyositis.

Ruxolitinib treatment led to unexpected hair regrowth in a patient with alopecia universalis.

Rituximab therapy successfully treated a patient's complete body hair loss and was effective for six years.

The document's conclusion cannot be provided because the document is not readable or understandable.

Papulopustular rosacea is an inflammatory skin condition treatable with lifestyle changes and medications.

In 2002, various skin reactions were reported due to different drugs, including allergies, hair loss, skin lesions, and other skin conditions.

Methotrexate treats various disorders by inhibiting DNA synthesis, but careful monitoring is needed to avoid toxicity and manage side effects.

A woman's eyelashes grew thicker and longer after taking topiramate, but returned to normal when she stopped the medication.

The author found the Dermatology Nurses’ Association’s annual meeting valuable for both learning and making friends.

Psoriasis patients are willing to pay less than the cost of biologic treatments for remission and don't expect complete or long-term symptom clearance.

Watching, not removing, skin growths with moderate atypia and positive edges is okay; patients may get melanoma elsewhere, especially if they've had it before.

Hydroxychloroquine may cause false results in tuberculosis tests for patients with autoimmune skin diseases.